Ya-xi Shang
- Infectious Diseases top 10%
- Complementary and alternative medicine top 2%
- Pharmacology top 5%
- Molecular Biology
- General Health Professions
- Co-authors
- Jianping LiuMing YangNicola RobinsonHui LuoChen ShenRuiting WangYuqi LiJing Li
- Topics
- COVID-19 Clinical Research Studies (2 papers)Andrographolide Research and Applications (1 paper)SARS-CoV-2 and COVID-19 Research (1 paper)
- Partner nations
- ChinaUnited KingdomNorway
In The Last Decade
Ya-xi Shang
4 papers receiving 464 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Infectious Diseases 169
- Complementary and alternative medicine 162
- Pharmacology 140
- Molecular Biology 81
- General Health Professions 49
Countries citing papers authored by Ya-xi Shang
This map shows the geographic impact of Ya-xi Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-xi Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-xi Shang more than expected).
Fields of papers citing papers by Ya-xi Shang
This network shows the impact of papers produced by Ya-xi Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-xi Shang. The network helps show where Ya-xi Shang may publish in the future.
Co-authorship network of co-authors of Ya-xi Shang
This figure shows the co-authorship network connecting the top 25 collaborators of Ya-xi Shang. A scholar is included among the top collaborators of Ya-xi Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya-xi Shang. Ya-xi Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 20 | |
| 3 | 16 | |
| 4 | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programsbreakdown → | 436 |
About Ya-xi Shang
Ya-xi Shang is a scholar working on Complementary and alternative medicine, Nephrology and Infectious Diseases, having authored 4 papers that have together received 480 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), Andrographolide Research and Applications (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Complementary and alternative medicine (162 citations), Pharmacology (140 citations) and Infectious Diseases (169 citations). Ya-xi Shang has collaborated with scholars based in China, United Kingdom and Norway. Frequent co-authors include Jianping Liu, Ming Yang, Nicola Robinson, Hui Luo, Chen Shen, Ruiting Wang, Yuqi Li, Jianping Liu, Jing Li and Trine Stub. Their work appears in journals such as Frontiers in Pharmacology, Trials and Chinese Journal of Integrative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.